Briacell Therapeutics Corp (BCTX)

$4.07 -0.02 (-0.61%)
Market Cap 29.51M
Revenue (ttm) 0.00
Net Income (ttm) -26.31M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 175,400
Avg Vol 499,028
Day's Range N/A - N/A
Shares Out 7.25M
Stochastic %K 15%
Beta 1.42
Analysts Strong Buy
Price Target $40.00

Company Profile

BriaCell Therapeutics Corp., a pre-clinical stage immuno-oncology company, engages in developing targeted immunotherapies to transform cancer care. Its lead candidate is Bria-IMT, a targeted immunotherapy program against end-stage breast cancer that is in Phase 3 clinical trials. The company develops Bria-OTS, a personalized off-the-shelf immunotherapy; and a soluble CD80 protein therapeutic that acts as a stimulator of the immune system and an immune checkpoint inhibitor. It has a license agree...

Industry: Biotechnology
Sector: Healthcare
Phone: 604 921 1810
Fax: 604 921 1898
Address:
Bellevue Centre, Suite 300 235 -15th Street, West Vancouver, Canada
BTC3030
BTC3030 Feb. 16 at 10:59 PM
$BCTX Citadel 9.99% ownership stake
1 · Reply
BTC3030
BTC3030 Feb. 16 at 2:36 AM
$BCTX offering should fund them thru phase 3 then we get bought out. Enjoy!
1 · Reply
GrowerWJR
GrowerWJR Feb. 15 at 10:51 PM
$BCTX idk how the company still sells the 1H 26 for interim analysis target date. The enrollment was at 160 in December. The only way to get 144 events in 1H 26 is whether the drug is not working or they miraculously enrolled few hundred patients in few months.
1 · Reply
Rohtan
Rohtan Feb. 14 at 7:19 PM
$BCTX let’s welcome 3s in coming weeks
1 · Reply
JediGreen
JediGreen Feb. 14 at 2:22 PM
$BCTX March 5. Shareholder meeting. 
1 · Reply
saleh1010
saleh1010 Feb. 13 at 6:22 PM
$BCTX hi guys can anyone give me what’s the best time to buy this company
4 · Reply
JediGreen
JediGreen Feb. 13 at 6:01 PM
$BCTX February video uploaded on Renmark for people. I haven’t watched it yet but going to right now. Should answer a lot of questions people may have.
5 · Reply
JediGreen
JediGreen Feb. 13 at 5:51 PM
$BCTX Renmark Virtual Non-Deal Roadshow: TSX - BCT | NASDAQ - BCTX (ID 2854) https://renmark-drupal.s3.amazonaws.com/vndr/briacell-therapeutics-corp/2026-02-12-11-00-00/index.html
0 · Reply
fishonthemoon
fishonthemoon Feb. 13 at 1:52 PM
$BCTX Just saw $BCTX commercial on Fox Business network. Pretty good ad.
0 · Reply
JediGreen
JediGreen Feb. 13 at 7:57 AM
$BCTX non deal roadshow - Google Search https://www.google.com/search?q=non+deal+roadshow&sca_esv=dc93c5be23b05f35&source=hp&ei=CdiOaZa3K7TBp84Pk5Sj-Qk&biw=430&bih=721&oq=non+deal+road&gs_lp=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_or2CCjm7oGBAgBGAqSBwQxMC43oAfyYbIHAzcuN7gHmwvCBwgwLjEuMTMuM8gHW4AIAA&sclient=mobile-gws-wiz-hp#lfId=ChxjMe
1 · Reply
Latest News on BCTX
BriaCell Patients' Images Show Regression and Resolution of Metastasized Tumors and Immune Activation

Jan 28, 2026, 7:30 AM EST - 19 days ago

BriaCell Patients' Images Show Regression and Resolution of Metastasized Tumors and Immune Activation

BriaCell Highlights Extended >18-47 Months Survival in Phase 2 Metastatic Breast Cancer Patients

Jan 27, 2026, 7:30 AM EST - 20 days ago

BriaCell Highlights Extended >18-47 Months Survival in Phase 2 Metastatic Breast Cancer Patients

BriaCell Therapeutics Announces Closing of US$30 million Public Offering

Jan 15, 2026, 4:05 PM EST - 4 weeks ago

BriaCell Therapeutics Announces Closing of US$30 million Public Offering

BriaCell Therapeutics Announces Pricing of $30 million Public Offering

Jan 13, 2026, 9:00 PM EST - 4 weeks ago

BriaCell Therapeutics Announces Pricing of $30 million Public Offering

BriaCell Reports Sustained Complete Resolution of Lung Metastasis in Bria-OTS™ Patient

Jan 13, 2026, 7:30 AM EST - 4 weeks ago

BriaCell Reports Sustained Complete Resolution of Lung Metastasis in Bria-OTS™ Patient

“Eleven clinical trials that will shape medicine in 2026” – BriaCell Phase 3 Trial Featured in Nature Medicine

Dec 18, 2025, 7:30 AM EST - 2 months ago

“Eleven clinical trials that will shape medicine in 2026” – BriaCell Phase 3 Trial Featured in Nature Medicine

BriaCell Presents Outstanding Phase 2 Survival & Promising Phase 3 Clinical Data at SABCS® 2025

Dec 10, 2025, 7:30 AM EST - 2 months ago

BriaCell Presents Outstanding Phase 2 Survival & Promising Phase 3 Clinical Data at SABCS® 2025

BriaCell's Phase 3 Patient Enrollment on Track for 1H2026 Topline Data Readout

Dec 9, 2025, 7:30 AM EST - 2 months ago

BriaCell's Phase 3 Patient Enrollment on Track for 1H2026 Topline Data Readout

BriaCell to Present Phase 2 Survival & Phase 3 Clinical Data at SABCS® 2025

Dec 2, 2025, 7:30 AM EST - 2 months ago

BriaCell to Present Phase 2 Survival & Phase 3 Clinical Data at SABCS® 2025

BriaCell to Highlight Positive Phase 2 & Phase 3 Clinical Data at SABCS® 2025

Nov 25, 2025, 7:30 AM EST - 2 months ago

BriaCell to Highlight Positive Phase 2 & Phase 3 Clinical Data at SABCS® 2025

BriaCell and Receptor.AI to Collaborate on AI Driven Small Molecule Cancer Therapeutics

Nov 20, 2025, 7:30 AM EST - 3 months ago

BriaCell and Receptor.AI to Collaborate on AI Driven Small Molecule Cancer Therapeutics

BriaCell Selected to Present Phase 2 & 3 Clinical Data at SABCS® 2025

Nov 18, 2025, 7:30 AM EST - 3 months ago

BriaCell Selected to Present Phase 2 & 3 Clinical Data at SABCS® 2025

BriaCell Presents Robust Anti-Cancer Activity of Bria-OTS+™ at SITC 2025

Nov 7, 2025, 7:30 AM EST - 3 months ago

BriaCell Presents Robust Anti-Cancer Activity of Bria-OTS+™ at SITC 2025

BriaCell to Present Robust Anti-Cancer Activity of Bria-OTS+™ in Breast and Prostate Cancer Models

Nov 4, 2025, 7:30 AM EST - 3 months ago

BriaCell to Present Robust Anti-Cancer Activity of Bria-OTS+™ in Breast and Prostate Cancer Models

BriaCell Receives Positive Recommendation from Data Safety Monitoring Board (DSMB) for Phase 3 Study in Metastatic Breast Cancer

Oct 22, 2025, 7:30 AM EDT - 4 months ago

BriaCell Receives Positive Recommendation from Data Safety Monitoring Board (DSMB) for Phase 3 Study in Metastatic Breast Cancer

BriaCell Adds Key Clinical Sites in Phase 3 Metastatic Breast Cancer Study

Oct 21, 2025, 7:50 AM EDT - 4 months ago

BriaCell Adds Key Clinical Sites in Phase 3 Metastatic Breast Cancer Study

BriaCell Announces Collaboration with MSK Accelerator to Advance Bria-OTS+™ for Breast Cancer

Oct 21, 2025, 7:30 AM EDT - 4 months ago

BriaCell Announces Collaboration with MSK Accelerator to Advance Bria-OTS+™ for Breast Cancer

BriaCell Presents Phase 3 Clinical Biomarker Data at ESMO 2025

Oct 20, 2025, 7:30 AM EDT - 4 months ago

BriaCell Presents Phase 3 Clinical Biomarker Data at ESMO 2025

BriaCell to Present Positive Clinical Biomarker Data of Phase 3 Study at ESMO 2025

Oct 13, 2025, 7:30 AM EDT - 4 months ago

BriaCell to Present Positive Clinical Biomarker Data of Phase 3 Study at ESMO 2025

BriaCell to Present Bria-OTS+™ Preclinical Data at SITC 2025 Annual Meeting

Oct 3, 2025, 7:30 AM EDT - 4 months ago

BriaCell to Present Bria-OTS+™ Preclinical Data at SITC 2025 Annual Meeting

BriaCell's Bria-OTS+™ Mechanism of Action Validated in Highly Rated Peer Reviewed Cancer Journal

Aug 26, 2025, 7:30 AM EDT - 6 months ago

BriaCell's Bria-OTS+™ Mechanism of Action Validated in Highly Rated Peer Reviewed Cancer Journal

BriaCell Awarded $2 Million NCI Grant to Advance Bria-PROS+™ in Prostate Cancer

Aug 25, 2025, 7:30 AM EDT - 6 months ago

BriaCell Awarded $2 Million NCI Grant to Advance Bria-PROS+™ in Prostate Cancer

BriaCell Announces Proposed Effective Date of Share Consolidation

Aug 21, 2025, 12:00 PM EDT - 6 months ago

BriaCell Announces Proposed Effective Date of Share Consolidation

BriaCell Selected for MSK's 2025 Therapeutics Accelerator Program for Bria-OTS+™ for Cancer

Aug 13, 2025, 7:30 AM EDT - 6 months ago

BriaCell Selected for MSK's 2025 Therapeutics Accelerator Program for Bria-OTS+™ for Cancer

BriaCell Adds UCLA Health as Key Site in Pivotal Phase 3 Breast Cancer Study

Jul 31, 2025, 7:30 AM EDT - 7 months ago

BriaCell Adds UCLA Health as Key Site in Pivotal Phase 3 Breast Cancer Study

BriaCell Awarded New Zealand Patent for its Whole Cell Technology

Jul 30, 2025, 7:30 AM EDT - 7 months ago

BriaCell Awarded New Zealand Patent for its Whole Cell Technology

BriaCell's Subsidiary, BriaPro, Files Patent Application for Immuno-Oncology Platform with Novel Multitargeting Agents

Jul 29, 2025, 7:30 AM EDT - 7 months ago

BriaCell's Subsidiary, BriaPro, Files Patent Application for Immuno-Oncology Platform with Novel Multitargeting Agents

BriaCell Announces Two Clinical Data Poster Presentations at ESMO 2025

Jul 25, 2025, 7:30 AM EDT - 7 months ago

BriaCell Announces Two Clinical Data Poster Presentations at ESMO 2025

BriaCell Therapeutics Announces Closing of $15 million Public Offering

Jul 16, 2025, 4:05 PM EDT - 7 months ago

BriaCell Therapeutics Announces Closing of $15 million Public Offering

BriaCell Therapeutics Announces Pricing of $15 million Public Offering

Jul 15, 2025, 3:05 PM EDT - 7 months ago

BriaCell Therapeutics Announces Pricing of $15 million Public Offering

BriaCell Adds Mayo Clinic to Phase 3 Study in Metastatic Breast Cancer

Jul 15, 2025, 7:30 AM EDT - 7 months ago

BriaCell Adds Mayo Clinic to Phase 3 Study in Metastatic Breast Cancer

BriaCell's Bria-IMT™ Demonstrates Survival Advantage over Trodelvy® and Control Group in Metastatic Breast Cancer

Jul 11, 2025, 7:30 AM EDT - 7 months ago

BriaCell's Bria-IMT™ Demonstrates Survival Advantage over Trodelvy® and Control Group in Metastatic Breast Cancer

BriaCell Reports Complete and Sustained Resolution of Brain Metastasis and Sustained Regression of Orbital Metastasis in “Eye-Bulging” Breast Cancer Patient

Jul 10, 2025, 7:30 AM EDT - 7 months ago

BriaCell Reports Complete and Sustained Resolution of Brain Metastasis and Sustained Regression of Orbital Metastasis in “Eye-Bulging” Breast Cancer Patient

BriaCell Patient Achieves Sustained Complete Resolution of Lung Metastasis in Bria-OTS™ Metastatic Breast Cancer Study

Jul 9, 2025, 7:30 AM EDT - 7 months ago

BriaCell Patient Achieves Sustained Complete Resolution of Lung Metastasis in Bria-OTS™ Metastatic Breast Cancer Study

BriaCell Phase 2 Survival Achievement: 52% of Patients Surpass One-Year Milestone in Metastatic Breast Cancer

Jul 8, 2025, 7:30 AM EDT - 7 months ago

BriaCell Phase 2 Survival Achievement: 52% of Patients Surpass One-Year Milestone in Metastatic Breast Cancer

BriaCell Highlights Additional Phase 3 Clinical Sites Including Los Angeles Cancer Network and Smilow Cancer Hospital at Yale New Haven

Jul 2, 2025, 7:30 AM EDT - 8 months ago

BriaCell Highlights Additional Phase 3 Clinical Sites Including Los Angeles Cancer Network and Smilow Cancer Hospital at Yale New Haven

BriaCell Announces Positive Recommendation from Data Safety Monitoring Board for Pivotal Phase 3 Study in Metastatic Breast Cancer

Jun 24, 2025, 7:30 AM EDT - 8 months ago

BriaCell Announces Positive Recommendation from Data Safety Monitoring Board for Pivotal Phase 3 Study in Metastatic Breast Cancer

BriaCell Announces Virtual Investor Presentations on Thursday, June 12 and Thursday, June 26

Jun 4, 2025, 7:30 AM EDT - 9 months ago

BriaCell Announces Virtual Investor Presentations on Thursday, June 12 and Thursday, June 26

BriaCell Reports Robust Overall Survival and Clinical Benefit Data at ASCO 2025

Jun 2, 2025, 7:30 AM EDT - 9 months ago

BriaCell Reports Robust Overall Survival and Clinical Benefit Data at ASCO 2025

BriaCell Bria-OTS™ Phase 1/2 Study Clears Safety Evaluation; Doses First Patient in Combination with Checkpoint Inhibitor

May 27, 2025, 7:30 AM EDT - 9 months ago

BriaCell Bria-OTS™ Phase 1/2 Study Clears Safety Evaluation; Doses First Patient in Combination with Checkpoint Inhibitor

BriaCell Abstracts Showcase Positive Survival and Clinical Benefit Data at ASCO 2025

May 23, 2025, 7:30 AM EDT - 9 months ago

BriaCell Abstracts Showcase Positive Survival and Clinical Benefit Data at ASCO 2025

BriaCell CEO Letter to Shareholders

May 20, 2025, 7:30 AM EDT - 9 months ago

BriaCell CEO Letter to Shareholders

BriaCell Reports “Late-Breaker” Phase 3 Data at AACR 2025: Positive Tolerability Profile and Potential Response Biomarkers Identified

Apr 30, 2025, 7:30 AM EDT - 10 months ago

BriaCell Reports “Late-Breaker” Phase 3 Data at AACR 2025: Positive Tolerability Profile and Potential Response Biomarkers Identified

BriaCell Therapeutics Announces Closing of $13.8 million Public Offering

Apr 28, 2025, 4:05 PM EDT - 10 months ago

BriaCell Therapeutics Announces Closing of $13.8 million Public Offering

BriaCell Presents Benchmark Beating Survival and Clinical Benefit at AACR 2025; Advancements in Next Generation Bria-OTS+™ Development

Apr 28, 2025, 7:30 AM EDT - 10 months ago

BriaCell Presents Benchmark Beating Survival and Clinical Benefit at AACR 2025; Advancements in Next Generation Bria-OTS+™ Development

BriaCell Therapeutics Announces Pricing of $13.8 million Public Offering

Apr 24, 2025, 8:00 PM EDT - 10 months ago

BriaCell Therapeutics Announces Pricing of $13.8 million Public Offering

Nano-Cap BriaCell Confirms Full Resolution Of Lung Metastasis In Breast Cancer Trial, Stock Shoots Higher

Apr 24, 2025, 10:11 AM EDT - 10 months ago

Nano-Cap BriaCell Confirms Full Resolution Of Lung Metastasis In Breast Cancer Trial, Stock Shoots Higher

BriaCell Confirms 100% Resolution of Lung Metastasis with Bria-OTS™

Apr 24, 2025, 7:30 AM EDT - 10 months ago

BriaCell Confirms 100% Resolution of Lung Metastasis with Bria-OTS™

BriaCell Announces Four Clinical Data Presentations at ASCO 2025

Apr 23, 2025, 7:30 AM EDT - 10 months ago

BriaCell Announces Four Clinical Data Presentations at ASCO 2025

BriaCell Enrollment Pace Accelerating in Phase 3 Clinical Study in Advanced Metastatic Breast Cancer (Bria-ABC)

Apr 22, 2025, 7:30 AM EDT - 10 months ago

BriaCell Enrollment Pace Accelerating in Phase 3 Clinical Study in Advanced Metastatic Breast Cancer (Bria-ABC)

BTC3030
BTC3030 Feb. 16 at 10:59 PM
$BCTX Citadel 9.99% ownership stake
1 · Reply
BTC3030
BTC3030 Feb. 16 at 2:36 AM
$BCTX offering should fund them thru phase 3 then we get bought out. Enjoy!
1 · Reply
GrowerWJR
GrowerWJR Feb. 15 at 10:51 PM
$BCTX idk how the company still sells the 1H 26 for interim analysis target date. The enrollment was at 160 in December. The only way to get 144 events in 1H 26 is whether the drug is not working or they miraculously enrolled few hundred patients in few months.
1 · Reply
Rohtan
Rohtan Feb. 14 at 7:19 PM
$BCTX let’s welcome 3s in coming weeks
1 · Reply
JediGreen
JediGreen Feb. 14 at 2:22 PM
$BCTX March 5. Shareholder meeting. 
1 · Reply
saleh1010
saleh1010 Feb. 13 at 6:22 PM
$BCTX hi guys can anyone give me what’s the best time to buy this company
4 · Reply
JediGreen
JediGreen Feb. 13 at 6:01 PM
$BCTX February video uploaded on Renmark for people. I haven’t watched it yet but going to right now. Should answer a lot of questions people may have.
5 · Reply
JediGreen
JediGreen Feb. 13 at 5:51 PM
$BCTX Renmark Virtual Non-Deal Roadshow: TSX - BCT | NASDAQ - BCTX (ID 2854) https://renmark-drupal.s3.amazonaws.com/vndr/briacell-therapeutics-corp/2026-02-12-11-00-00/index.html
0 · Reply
fishonthemoon
fishonthemoon Feb. 13 at 1:52 PM
$BCTX Just saw $BCTX commercial on Fox Business network. Pretty good ad.
0 · Reply
JediGreen
JediGreen Feb. 13 at 7:57 AM
$BCTX non deal roadshow - Google Search https://www.google.com/search?q=non+deal+roadshow&sca_esv=dc93c5be23b05f35&source=hp&ei=CdiOaZa3K7TBp84Pk5Sj-Qk&biw=430&bih=721&oq=non+deal+road&gs_lp=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_or2CCjm7oGBAgBGAqSBwQxMC43oAfyYbIHAzcuN7gHmwvCBwgwLjEuMTMuM8gHW4AIAA&sclient=mobile-gws-wiz-hp#lfId=ChxjMe
1 · Reply
JediGreen
JediGreen Feb. 13 at 7:32 AM
$BCTX Bullish Baby
0 · Reply
JediGreen
JediGreen Feb. 13 at 7:32 AM
$BCTX BriaCell Therapeutics Corp. | Renmark Financial Communications https://renmarkfinancial.com/companies/briacell-therapeutics-corp
0 · Reply
JediGreen
JediGreen Feb. 13 at 6:59 AM
$BCTX
0 · Reply
JediGreen
JediGreen Feb. 13 at 6:59 AM
$BCTX update BCTX Short Volume | ChartExchange https://chartexchange.com/symbol/nasdaq-bctx/short-volume/
0 · Reply
Stock_Catcher
Stock_Catcher Feb. 13 at 3:19 AM
Fortune Friday Watchlist Pt. 6 $VKTX $PGY $MVIS $NNDM $BCTX Let's Do Great Tomorrow !
2 · Reply
Kirubin
Kirubin Feb. 12 at 2:48 PM
$BCTX 🫣🤣🫡🫵🏽
3 · Reply
JediGreen
JediGreen Feb. 11 at 11:53 PM
$BCTX wow I’m seeing like 56 percent sort volume and they hardly got it down.
3 · Reply
JediGreen
JediGreen Feb. 11 at 11:52 PM
$BCTX Update BCTX Short Volume | ChartExchange https://chartexchange.com/symbol/nasdaq-bctx/short-volume/
0 · Reply
Forestbird
Forestbird Feb. 11 at 9:08 PM
$BCTX intereating article
1 · Reply
Forestbird
Forestbird Feb. 11 at 9:06 PM
$BCTX https://2f04c740.delivery.rocketcdn.me/wp-content/uploads/2026/01/Nature-Medicine-Eleven-clinical-trials-that-will-shape-medicine-in-2026-Dec2025.pdf
0 · Reply
BadensBester
BadensBester Feb. 11 at 7:45 PM
$BCTX in with 2,5k shares
0 · Reply
BadensBester
BadensBester Feb. 11 at 7:45 PM
$BCTX in with 2,5 shares
0 · Reply